tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VRTX Stock Latest News

Vertex Pharmaceuticals: Strong Performance and Promising Pipeline Drive Buy Rating
RatingsVertex Pharmaceuticals: Strong Performance and Promising Pipeline Drive Buy Rating
1d ago
VRTX
Vertex Pharmaceuticals presents new data on ALYFTREK at ECFS Conference
PremiumThe Fly
Vertex Pharmaceuticals presents new data on ALYFTREK at ECFS Conference
2d ago
VRTX
BMO Capital Markets Reiterates ‘Buy’ Rating on Eli Lilly Stock (LLY)
PremiumMarket News
BMO Capital Markets Reiterates ‘Buy’ Rating on Eli Lilly Stock (LLY)
9d ago
BMO
LLY
Vertex Pharmaceuticals: Strong Buy Rating Backed by Leadership in NAV1.8 Inhibitors and Strategic Collaborations
PremiumRatings
Vertex Pharmaceuticals: Strong Buy Rating Backed by Leadership in NAV1.8 Inhibitors and Strategic Collaborations
11d ago
VRTX
BMO says Eli Lilly ‘well-priced deal’ to expand presence in pain a positive
PremiumThe Fly
BMO says Eli Lilly ‘well-priced deal’ to expand presence in pain a positive
12d ago
LLY
VRTX
Vertex Pharmaceuticals downgraded to Hold from Buy at Erste Group
PremiumThe FlyVertex Pharmaceuticals downgraded to Hold from Buy at Erste Group
16d ago
VRTX
Vertex Pharmaceuticals Launches $4 Billion Stock Buyback
Premium
Company Announcements
Vertex Pharmaceuticals Launches $4 Billion Stock Buyback
20d ago
8K
VRTX
Vertex Pharmaceuticals: Strategic Positioning and Promising Growth Prospects Underpin Buy Rating
Premium
Ratings
Vertex Pharmaceuticals: Strategic Positioning and Promising Growth Prospects Underpin Buy Rating
20d ago
VRTX
Vertex Pharmaceuticals Holds Annual Shareholder Meeting
PremiumCompany Announcements
Vertex Pharmaceuticals Holds Annual Shareholder Meeting
25d ago
8K
VRTX
Vertex Pharmaceuticals: Strong Growth and Promising Pipeline Justify Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Strong Growth and Promising Pipeline Justify Buy Rating
27d ago
VRTX
Skechers, Shopify, Diamondback, Vertex, Turtle Beach: Trending by Analysts
PremiumWeekend Updates
Skechers, Shopify, Diamondback, Vertex, Turtle Beach: Trending by Analysts
29d ago
SKX
FANG
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
BOLT
HRTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
MRK
ATHE
LLY, VRTX, or ABBV: Which Healthcare Stock Is the Best Pick?
Premium
Market News
LLY, VRTX, or ABBV: Which Healthcare Stock Is the Best Pick?
1M ago
LLY
ABBV
Beam Therapeutics price target lowered to $55 from $78 at Guggenheim
Premium
The Fly
Beam Therapeutics price target lowered to $55 from $78 at Guggenheim
1M ago
BEAM
VRTX
Vertex Pharmaceuticals: Hold Rating Amid Revenue Misses, Pipeline Challenges, and Slow Product Transitions
PremiumRatings
Vertex Pharmaceuticals: Hold Rating Amid Revenue Misses, Pipeline Challenges, and Slow Product Transitions
1M ago
VRTX
Vertex Pharmaceuticals price target raised to $499 from $467 at Barclays
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $499 from $467 at Barclays
1M ago
VRTX
Wolfe downgrades Vertex Pharmaceuticals on slow pain launch
PremiumThe Fly
Wolfe downgrades Vertex Pharmaceuticals on slow pain launch
1M ago
VRTX
Vertex Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Vertex Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
1M ago
VRTX
Vertex downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlyVertex downgraded to Peer Perform from Outperform at Wolfe Research
1M ago
VRTX
Vertex Pharmaceuticals price target raised to $621 from $617 at Goldman Sachs
Premium
The Fly
Vertex Pharmaceuticals price target raised to $621 from $617 at Goldman Sachs
1M ago
VRTX
Vertex Pharmaceuticals price target lowered to $442 from $450 at Scotiabank
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $442 from $450 at Scotiabank
1M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >